GSK to Stop Paying Doctors for Promoting Its Products

In the history of drug litigation, one fact that clearly emerged is that companies paid doctors a lot of money or provided a great deal of free samples and gifts to promote their drugs.  Also, sales reps had sales targets for specific doctors and were often given bonuses based on prescriptions from doctors in their [...]

December 19th, 2013|Drug and Medical Device Litigation|Comments Off on GSK to Stop Paying Doctors for Promoting Its Products

GSK Continues to Pay for Avandia Claims

Problems with Avandia continue to haunt GSK. Previously, GSK has settled thousands of claims over Avandia while claiming there is nothing wrong with the onetime diabetes wonder drug.  And now confronted with allegations brought by the State of Utah the drug giant defrauded the state’s Medicaid program through allegedly false and misleading marketing of Avandia, [...]

December 10th, 2013|Avandia Diabetes Drug, Drug and Medical Device Litigation|Comments Off on GSK Continues to Pay for Avandia Claims

Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn.  Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]

November 7th, 2013|Actos Diabetes Drug, Avandia Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Lipitor, Transvaginal Mesh|Comments Off on Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

Drugs, Advertising, and Risks Associated with Direct to Consumer Ads

If you have watched a news program, sporting event, or network television show recently you have seen multiple ads for drugs or devices that will change your life.  Whether it is “Larry the cable guy” for the “purple” pill, a handsome athletic looking couple looking for the right moment assisted by a “blue” pill, an [...]

October 23rd, 2013|Drug and Medical Device Litigation|Comments Off on Drugs, Advertising, and Risks Associated with Direct to Consumer Ads

Are Too Many Doctors Simply Sales People for Big Pharma?

Big Pharma paid doctors more than $1 billion in 2012 to act in various spokesperson capacities, for travel and meals, as well as research and royalties, which is significantly more than reported in 2011.  According to a new data reported in the Financial Times, that figure only includes the 12 leading drug makers who actually [...]

May 29th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Are Too Many Doctors Simply Sales People for Big Pharma?